help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agustí, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agustí, A.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 675-676, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200712-1790ED


Editorials

Physical Activity and Chronic Obstructive Pulmonary Disease

Alvar Agustí, M.D., F.R.C.P.

Servei Respiratori (Hospital Universitari Son Dureta)
Fundació Caubet-Cimera Illes Balears
and
CIBER Enfermedades Respiratorias
Mallorca, Spain

Physical activity, not to be confused with exercise tolerance, is an essential component of human life. Defined as any movement of the body produced by skeletal muscles that consumes oxygen (1), physical activity allows normal functioning during daily life, both at home and at work. In healthy subjects, regular physical activity improves health and prognosis. In patients, reduced physical activity is a marker of disease severity, often a poor prognostic marker, and always a key contributor to reduced health status. Thus, a better understanding of the mechanisms contributing to reduced physical activity in disease, as well as to improved well-being in healthy subjects, is a matter of great interest.

Physical activity has only recently begun to be studied rigorously in patients with chronic obstructive pulmonary disease (COPD). We now know that, compared with healthy subjects, physical activity is reduced in patients with moderate to severe COPD (2, 3). We also know that physical activity is only modestly correlated with the degree of airflow obstruction (2, 3), the functional hallmark of COPD, indicating that other factors must be involved in limiting physical activity in these patients (4). Recently, Garcia-Aymerich and colleagues showed that physical activity reduces hospital admissions, the rate of lung function decline, and even mortality in patients with COPD (5, 6). However, many questions still remain unanswered, including the contribution of different mechanisms to reduced physical activity in these patients, or the effect of therapy on physical activity.

In this issue of the Journal (pp. 743–751), Watz and coworkers present novel data that help to better understand the contribution of different pulmonary and extrapulmonary factors to reduced physical activity in COPD (7). Traditionally, physical activity has been estimated from questionnaires and clinical interviews. Modern technology allowed Watz and colleagues to estimate physical activity much more precisely by using multisensor accelerometer armbands that record "steps per day" and calculate "energy expenditure" (7). Physical activity levels were estimated by dividing total daily energy expenditure by whole-night sleeping energy expenditure (7). Using this technique, the authors confirmed previous data (2, 3) and showed that more than two-thirds of a relatively large cohort (n = 170) of patients with stable COPD, covering the whole range of GOLD (Global Initiative for Chronic Obstructive Lung Disease) severity, have low physical activity (7). More interestingly, however, they used multivariate analysis to explore the relationship between a number of pulmonary and extrapulmonary factors and reduced physical activity in these patients (7). They found that their "best" model was able to explain only 37% of the total variance of physical activity (7), suggesting that factors not included in the analysis contribute significantly to reduced physical activity in COPD. The degree of airflow obstruction accounted for about two-thirds of this 37% of variance, whereas the combination of two extrapulmonary factors (systemic inflammation and left cardiac dysfunction) explained the remaining third (7). Finally, and contrary to what might have been expected, the authors found that the presence of nutritional depletion, depression, anemia, peripheral arterial disease, pulmonary hypertension, and/or peripheral muscle strength did not contribute significantly to physical activity in these patients (7).

The study by Watz and colleagues (7) provides interesting data that permit better understanding of the mechanisms contributing to reduced physical activity in patients with COPD. However, as any good piece of research, this study also raises many questions. For instance, despite the fact that a relatively large number of pulmonary and extrapulmonary factors that can potentially reduce physical activity in these patients were included in the analyses, as well as a number of potential lifestyle confounders (e.g., the level of education, regular alcohol consumption, and smoking status, among others), these could explain less than 50% of the total physical activity variance. What other pulmonary or extrapulmonary factor(s) are we missing? To name only a few, and just to stimulate further thoughts, I would suggest that future studies consider including in the model the following: the degree of lung hyperinflation, which has prognostic value in these patients (8), can limit oxygen delivery to tissues (9), and may contribute to systemic inflammation (10); the presence of systemic endothelial dysfunction (11); other inflammatory markers (e.g., IL-6, a cytokine involved in the sense of "fatigue" in athletes [12]); and/or the possibility of abnormal oxidative metabolism in the mitochondrial of skeletal muscle (13). Likewise, diastolic left heart dysfunction (as assessed by echocardiography and N-terminal pro–B-type natriuretic peptide levels) and systemic inflammation (as assessed by the plasma values of C-reactive protein and fibrinogen) contributed, independently of the degree of airflow limitation, to physical activity in COPD (7). We know that left heart failure occurs in about 20% of elderly patients with COPD, and that in about a half of these patients this is of the diastolic type (14). Have Watz and coworkers identified a new form of "cardiac dysfunction," similar to the skeletal muscle dysfunction known to occur in COPD (15) and also believed to be related to systemic inflammation (16)? The answer to these and others questions that investigators in the field may raise from the findings of Watz and coworkers (7) may be important because they may identify domains of COPD amenable to therapeutic intervention.

FOOTNOTES

Conflict of Interest Statement: A.A. has no financial relationship with a commercial entity that has an interest in the subject of this manuscript.

REFERENCES

  1. Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109–3116.[Free Full Text]
  2. Schonhofer B, Ardes P, Geibel M, Kohler D, Jones PW. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J 1997;10:2814–2819.[Abstract]
  3. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:972–977.[Abstract/Free Full Text]
  4. Garcia-Aymerich J, Félez MA, Escarrabill J, Marrades RM, Morera J, Elosua R, Antó JM. Physical activity and its determinants in severe chronic obstructive pulmonary disease. Med Sci Sports Exerc 2004;36:1667–1673.
  5. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772–778.[Abstract/Free Full Text]
  6. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–463.[Abstract/Free Full Text]
  7. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008;177:743–751.[Abstract/Free Full Text]
  8. Casanova C, Cote C, de Torres JP, Guirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:591–597.[Abstract/Free Full Text]
  9. ERS Task Force on Standardization of Clinical Exercise Testing. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997;10:2662–2689.[CrossRef][Medline]
  10. Agustí A, Soriano JB. Dynamic hyperinflation and pulmonary inflammation: a potentially relevant relationship? European Respiratory Review 2006;15:68–71.[Abstract/Free Full Text]
  11. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DS. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. European Respiratory Review 1999;130:578–581.
  12. Robson-Ansley PJ, de Milander L, Collins M, Noakes TD. Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can J Appl Physiol 2004;29:411–418.[Medline]
  13. Sauleda J, García-Palmer FJ, Wiesner R, Tarraga S, Harting I, Tomás P, Gómez C, Saus C, Palou A, Agustí AGN. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1413–1417.[Medline]
  14. Rutten FH, Cramer M-JM, Grobbee DE, Sachs APE, Kirkels JH, Lammers J-WJ, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887–1894.[Abstract/Free Full Text]
  15. American Thoracic Society; European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159:S1–S40.[Free Full Text]
  16. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proc Am Thorac Soc 2007;4:522–525.[Abstract/Free Full Text]

Related articles in AJRCCM:

Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity: A Cross-sectional Study
Henrik Watz, Benjamin Waschki, Corinna Boehme, Martin Claussen, Thorsten Meyer, and Helgo Magnussen
AJRCCM 2008 177: 743-751. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
ChestHome page
J. Garcia-Aymerich, I. Serra, F. P. Gomez, E. Farrero, E. Balcells, D. A. Rodriguez, J. de Batlle, E. Gimeno, D. Donaire-Gonzalez, M. Orozco-Levi, et al.
Physical Activity and Clinical and Functional Status in COPD
Chest, July 1, 2009; 136(1): 62 - 70.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Agustí, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Agustí, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society